The apolipoprotein E(APOE)ε4 allelle is a well‐established risk factor for cognitive decline.Racial factors may mitigate its effects.However,APOEε4 has similar effects even among different racial groups.The APOE genotype in patients with Alzheimer’s disease may influence therapeutic decisions.